Daniel Pollard

736 total citations
26 papers, 253 citations indexed

About

Daniel Pollard is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Daniel Pollard has authored 26 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 7 papers in General Health Professions and 7 papers in Economics and Econometrics. Recurrent topics in Daniel Pollard's work include Diabetes Management and Research (10 papers), Diabetes Management and Education (7 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Daniel Pollard is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes Management and Education (7 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Daniel Pollard collaborates with scholars based in United Kingdom, Australia and Netherlands. Daniel Pollard's co-authors include Alan Brennan, Simon Heller, Khalida Ismail, Kirsty Winkley, Rebecca Upsher, Daniel Ståhl, Hasan Basarir, Daisy Elliott, Simon Dixon and Norman Waugh and has published in prestigious journals such as The Lancet, BMC Medicine and BMJ Open.

In The Last Decade

Daniel Pollard

24 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Pollard United Kingdom	9	141	56	41	32	26	26	253
Janice Lopez United States	9	196 1.4×	41 0.7×	62 1.5×	25 0.8×	17 0.7×	13	321
Bjørn Gjelsvik Norway	9	145 1.0×	55 1.0×	53 1.3×	22 0.7×	31 1.2×	25	240
Stephan Ruhla Germany	7	193 1.4×	42 0.8×	47 1.1×	16 0.5×	12 0.5×	7	312
Eberta Tan Singapore	8	132 0.9×	66 1.2×	33 0.8×	19 0.6×	10 0.4×	13	246
Karianne Fjeld Løvaas Norway	11	199 1.4×	55 1.0×	79 1.9×	19 0.6×	59 2.3×	24	280
Joël Cogneau France	10	85 0.6×	90 1.6×	28 0.7×	25 0.8×	10 0.4×	16	301
Sailesh Sankar United Kingdom	9	58 0.4×	39 0.7×	35 0.9×	12 0.4×	12 0.5×	29	252
U Reitberger Germany	8	133 0.9×	43 0.8×	74 1.8×	48 1.5×	11 0.4×	15	326
Rose Z.W. Ting China	9	265 1.9×	43 0.8×	151 3.7×	21 0.7×	15 0.6×	9	403
Natalie Wischer Australia	9	236 1.7×	35 0.6×	81 2.0×	6 0.2×	33 1.3×	19	314

Countries citing papers authored by Daniel Pollard

Since Specialization

Citations

This map shows the geographic impact of Daniel Pollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Pollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Pollard more than expected).

Fields of papers citing papers by Daniel Pollard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Pollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Pollard. The network helps show where Daniel Pollard may publish in the future.

Co-authorship network of co-authors of Daniel Pollard

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Pollard. A scholar is included among the top collaborators of Daniel Pollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Pollard. Daniel Pollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pollard, Daniel, Anju Keetharuth, Alan Brennan, et al.. (2025). A model based cost-utility analysis of Embedding referral to structured self-management education into standard practice (Embedding) compared to usual care for people with type 2 diabetes diagnosis in the last 12 months in England. BMJ Open. 15(2). e093327–e093327.

Franklin, Matthew, et al.. (2024). Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review. Advances in Therapy. 41(7). 2700–2722. 5 indexed citations

Pollard, Daniel, Alan Brennan, Melanie J. Davies, et al.. (2024). Cost-effectiveness analysis of two interventions to promote physical activity in a multiethnic population at high risk of diabetes: an economic evaluation of the 48-month PROPELS randomized controlled trial. BMJ Open Diabetes Research & Care. 12(2). e003516–e003516.

Breeze, Penny, et al.. (2023). Estimation of HbA1c after weight loss using a beta-regression for an economic evaluation of a behavioural weight management programme from the GLoW trial: a methodological study. The Lancet. 402. S75–S75. 1 indexed citations

Pollard, Daniel, et al.. (2022). An economic evaluation of triage tools for patients with suspected severe injuries in England. BMC Emergency Medicine. 22(1). 4–4. 1 indexed citations

Broadley, Melanie, Giesje Nefs, Bastiaan E. de Galan, et al.. (2022). Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application. BMJ Open. 12(2). e051651–e051651. 13 indexed citations

Khunti, Kamlesh, Simon J. Griffin, Alan Brennan, et al.. (2021). Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT. Health Technology Assessment. 25(77). 1–190. 13 indexed citations

Khunti, Kamlesh, Simon J. Griffin, Alan Brennan, et al.. (2021). Promoting physical activity in a multi-ethnic population at high risk of diabetes: the 48-month PROPELS randomised controlled trial. BMC Medicine. 19(1). 130–130. 18 indexed citations

Latimer, Nicholas, Daniel Pollard, Adrian Towse, et al.. (2021). Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi‐stakeholder, international workshop. BMC Health Services Research. 21(1). 412–412. 21 indexed citations

10.

Winkley, Kirsty, Rebecca Upsher, Daniel Ståhl, et al.. (2020). Systematic review and meta‐analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes. Diabetic Medicine. 37(5). 735–746. 23 indexed citations

11.

Winkley, Kirsty, Rebecca Upsher, Daniel Ståhl, et al.. (2020). Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review. Health Technology Assessment. 24(28). 1–232. 68 indexed citations

12.

Pollard, Daniel, et al.. (2019). PDB65 PRETRIAL MODELLING METHODS TO JUSTIFY AND INFORM THE DESIGN OF LARGE RCTS - EXPECTED VALUE OF SAMPLE INFORMATION FOR THE DAFNEPLUS DIABETES EDUCATION CLUSTER RCT. Value in Health. 22. S584–S584. 1 indexed citations

13.

Brennan, Alan & Daniel Pollard. (2019). PDB28 A HEALTH ECONOMIC AND DECISION MODELLING ANALYSIS PLAN FOR AN INTEGRATED DATABASE OF OVER 100 CLINICAL TRIALS MEASURING HYPOGLYCAEMIC ATTACKS FOR PEOPLE WITH DIABETES: A HEDMAP FOR HYPORESOLVE. Value in Health. 22. S577–S577. 1 indexed citations

14.

Latimer, Nicholas & Daniel Pollard. (2019). Pre-read document 1 : challenges in valuing and paying for combination regimens in oncology. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 1 indexed citations

15.

Pollard, Daniel, Alan Brennan, Simon Dixon, et al.. (2018). Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial. BMJ Open. 8(4). e016766–e016766. 28 indexed citations

16.

Goodacre, Steve, Kim Horspool, Neil Shephard, et al.. (2018). Selecting pregnant or postpartum women with suspected pulmonary embolism for diagnostic imaging: the DiPEP diagnostic study with decision-analysis modelling. Health Technology Assessment. 22(47). 1–230. 14 indexed citations

17.

Tappenden, Paul, Emma Simpson, Jean Hamilton, et al.. (2018). Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 37(3). 333–343. 2 indexed citations

18.

Brennan, Alan, et al.. (2017). Expected Value of Sample Information For Individual Level Simulation Models To Inform Stop/Go Decision Making By Public Research Funders: A Methodology for The Dafneplus Diabetes Education Cluster Rct. Value in Health. 20(9). A776–A776. 2 indexed citations

19.

Basarir, Hasan, Alan Brennan, Richard Jacques, et al.. (2016). COST-EFFECTIVENESS OF STRUCTURED EDUCATION IN CHILDREN WITH TYPE-1 DIABETES MELLITUS. International Journal of Technology Assessment in Health Care. 32(4). 203–211. 3 indexed citations

20.

Basarir, Hasan, Daniel Pollard, Alan Brennan, et al.. (2014). The Potential Value of Ongoing Support In Type-1 Diabetes Mellitus With Dafneplus: Exploratory Pre-Trial Cost-Effectiveness Analysis On Proposed Trial End-Point Target For 12-Month Hba1c Improvement. Value in Health. 17(7). A350–A350. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact